HopeStage
Back to all studies
RecruitingNCT06833788

Intravenous or oral iron after cesarean birth and postpartum depression

About this titleRead the official source — NCT06833788
Medication studyAges 18+France
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

What will I do during this study?

After a caesarean delivery, participants are randomly assigned to an iron infusion within five days or to oral iron for eight weeks. The study compares postpartum mood symptoms between these groups; the registry lists an assessment at eight weeks after delivery.

Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Participation duration
8 weeks after delivery

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 22, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
2,860
Sponsor
Assistance Publique - Hôpitaux de Paris
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
France
Age range
Over 18 Years
Official registry ID
NCT06833788
Official title
Show the full official title

Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression: a Multicentric Randomized Open-labelled Controlled Trial

Recruitment & locations

Recruiting

Paris

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Assistance Publique - Hôpitaux de Paris.

Does this study involve medication?

Yes. The study involves medication, including Ferric carboxymaltose IV and TIMOFÉROL®.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies